CF PharmTech (HKG:2652) is partnering with JD Health International (HKG:6618) to launch a number of respiratory and rhinology therapeutic products, according to a Hong Kong bourse filing Monday.
The firm said JD Health will serve as the exclusive online launch platform for a number of products over the next three years.